Search
According to forklog, Science Corporation, founded by former Neuralink president Max Hodak, has announced the appointment of Dr. Murat Gunel, Chair of Neurosurgery at Yale University, as its scientific advisor to lead preparations for the first human clinical trial of its biohybrid brain-computer interface (BCI). This technology incorporates lab-grown neurons embedded in sensors, allowing for natural integration with the human brain, differing from Neuralink's invasive approach. The trial is scheduled to commence in 2027 and will involve implanting pea-sized sensors on the brain surface of stroke patients to evaluate safety and signal acquisition capabilities. The company recently completed a $230 million Series C funding round, reaching a valuation of $1.5 billion.
-
C114 Communication Network -
Communication Home
